On November 28, 2019, the first Alpha DaRT procedure was performed in Russia, at the A. Tsyb Medical Radiological Research Center in Obninsk, in a patient diagnosed with metastatic breast cancer. Radiation Oncologist Dr. Razvan Galalae from Essen, Germany, performed the treatment with the support of Prof. Yona Keisari, Chief Scientific Officer of Alpha Tau and a co-inventor of Alpha DaRT. This patient is the first in a clinical trial of Alpha DaRT just initiated in Obninsk.
Breast cancer is the most common cancer among women in Russia, and is usually treated with beta or gamma radiation. Nonetheless, metastatic breast cancer is almost always fatal. Russian oncology team members who participated in the Alpha DaRT trial feel that this new technique, with its innovative mec